Bone marrow concentrate implantation alongside decompression of no benefit in ONFH treatment .
Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial
Int Orthop. 2018 Jul;42(7):1429-1435. doi: 10.1007/s00264-017-3650-8. Epub 2017 Oct 742 patients with osteonecrosis of the femoral head (ONFH) were randomized to core decompression with or without additional application of bone marrow aspirate concentrate (BMAC). The purpose of this study was to compare the rate of conversion to total hip arthroplasty (THA) during follow-up to 24 months. Results demonstrated no significant difference between the groups in the rate of eventual THA.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
